← Evidence map

TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2024

A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-naïve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms.

Dong-Mei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2024
2025
2026
this paperpooled itcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 37903861